{"result": "(\"entity\"<|>GSDVI<|>EVENT<|>Glycogen Storage Disease Type VI (GSDVI) is a rare metabolic disorder caused by a mutation in the liver isoform of glycogen phosphorylase, leading to various symptoms including hepatomegaly and hypoglycemia in early childhood.)\n##\n(\"entity\"<|>PYGL<|>ORGANIZATION<|>The PYGL gene located on chromosome 14q22.1 is responsible for encoding the liver isoform of glycogen phosphorylase, which is crucial for glycogenolysis.)\n##\n(\"entity\"<|>GLYCOGEN PHOSPHORYLASE<|>ORGANIZATION<|>Glycogen phosphorylase is an enzyme that catalyzes the breakdown of glycogen into glucose-1-phosphate, playing a key role in glucose metabolism.)\n##\n(\"entity\"<|>HEPATOMEGALY<|>EVENT<|>Hepatomegaly is a condition characterized by an enlarged liver, often associated with various metabolic disorders including GSDVI.)\n##\n(\"entity\"<|>HYPOGLYCEMIA<|>EVENT<|>Hypoglycemia refers to abnormally low blood sugar levels, which can occur in patients with GSDVI, especially after fasting.)\n##\n(\"entity\"<|>AMNIOCENTESIS<|>EVENT<|>Amniocentesis is a medical procedure used for prenatal diagnosis, including genetic testing for conditions like GSDVI.)\n##\n(\"relationship\"<|>GSDVI<|>PYGL<|>GSDVI is caused by a mutation in the PYGL gene, which is essential for glycogen metabolism<|>9)\n##\n(\"relationship\"<|>GSDVI<|>GLYCOGEN PHOSPHORYLASE<|>Glycogen phosphorylase is the enzyme affected in GSDVI, leading to the disease's symptoms<|>9)\n##\n(\"relationship\"<|>GSDVI<|>HEPATOMEGALY<|>Hepatomegaly is one of the clinical manifestations of GSDVI<|>7)\n##\n(\"relationship\"<|>GSDVI<|>HYPOGLYCEMIA<|>Hypoglycemia is a common symptom experienced by individuals with GSDVI<|>7)\n##\n(\"relationship\"<|>GSDVI<|>AMNIOCENTESIS<|>Amniocentesis can be used for prenatal diagnosis of GSDVI<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: actividad.\n\n#### 1.5.3. Recomendaciones dietéticas\n\nSe debe proporcionar un aporte elevado de HC complejos para reponer el glucógeno hepático que será movilizado posteriormente durante el ejercicio. El reparto de macronutrientes indicado sería: HC = 65%, lípidos = 20%, proteínas = 15-20%.\n\nAdemás, se recomienda la toma de HC de absorción rápida (sacarosa, glucosa o fructosa) antes de la realización de ejercicio físico aeróbico o dinámico, ya que en diversos estudios se ha observado una ligera mejoría de la tolerancia al mismo y una disminución del riesgo de rabdomiólisis inducida. No se ha observado beneficio con esta suplementación ante la actividad física\n---\nTema 14. Soporte nutricional en patologías con alteración en el procesamiento... 221\n\nisométrica. La dosis recomendada es 20 g en niños pequeños, y 30-40 g en adolescentes y adultos o incluso dosis de 20-30 g pero repetidas por cada hora de ejercicio. Existen estudios con mayor dosis de sacarosa (75 g en adultos), pero el efecto beneficioso parece ser de la misma magnitud que con dosis menores. Además hay que tener en cuenta que la toma de azúcares antes de iniciar el ejercicio puede disminuir la movilización de lípidos que se produce de forma normal cuando éste se realiza de forma prolongada, y de hecho con la suplementación de HC de absorción rápida el fenómeno second wind se minimiza o no se produce en muchos casos. A pesar de ello, como se ha comentado, la tolerancia al ejercicio es mayor.\n\nTambién se han realizado estudios con suplementos de creatina con resultados contradictorios. En un ensayo se observó mejoría de la capacidad ante ejercicio isométrico isquémico pero no frente a ejercicio no isquémico con dosis bajas (60 mg/kg/d). En otro ensayo clínico con suplementos de creatina a dosis altas (150 mg/kg/d) empeoró la tolerancia al ejercicio, por lo que parece que el efecto pudiera ser dosis-dependiente. Se han intentado otras estrategias como la suplementación con vitamina B6 o aminoácidos ramificados sin resultados satisfactorios que justifiquen su uso.\n\n## 1.6. Déficit de fosforilasa hepática, glucogenosis tipo VI o enfermedad de Hers (GSDVI)\n\n### 1.6.1. Fisiopatología y diagnóstico\n\nLa GSDVI se produce por la mutación de la isoforma hepática de la glucógeno fosforilasa (gen PYGL, 14q22.1), enzima limitante de la glucogenólisis, que cataliza la escisión de los enlaces α-1,4 del glucógeno liberando Glu-1-P. A diferencia de la GSDI la gluconeogénesis es eficaz, por lo que los niveles de glucemia se mantienen gracias a esta ruta metabólica.\n\nSe trata de una enfermedad rara, y de curso benigno que se manifiesta a edad temprana, generalmente durante la lactancia o infancia. La clínica consiste en hepatomegalia con elevación leve de transaminasas, hipoglucemia leve tras ayuno en caso de enfermedad, hipoglucemia cetósica tras ayuno durante toda la noche, hiperlipemia leve y retraso del crecimiento. A largo plazo puede aparecer osteoporosis en pacientes no tratados. Los síntomas mejoran con la edad y en la mayoría de los casos la hepatomegalia desaparece y los individuos alcanzan su talla diana. No se produce hiperlactacidemia, hiperuricemia, ni afectación muscular o cardiaca.\n\nEl diagnóstico se confirma mediante estudio genético, y en los casos en que éste no sea concluyente se realizará biopsia hepática para estudio histológico, en donde se muestra aumento del glucógeno hepático con aspecto deshilachado menos compacto que en otros tipos de GSD. La cuantificación de la actividad enzimática de la glucógeno fosforilasa también es po-\n\nsible en eritrocitos, leucocitos o tejido hepático, pero suele tener falsos negativos y tampoco la distingue de la GSDIX, ya que el déficit de fosforilasa kinasa disminuye la activación de la glucógeno fosforilasa.\n\nSe puede realizar diagnóstico prenatal mediante estudio genético de la mutación del caso índice familiar mediante amniocentesis o biopsia corial.\n\n### 1.6.2. Objetivos nutricionales y recomendaciones dietéticas\n\nHabitualmente los pacientes no precisan tratamiento para mantener los niveles de glucemia, ya que la enfermedad tiene un curso benigno. En caso de presentar hipoglucemias, más frecuente en los primeros años, se realizará una dieta rica en HC y ligeramente hiperproteica (15-25% del valor calórico total) con\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}